NCT03197506 Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03194971 NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy Status COMPLETED Phase N/A
NCT03174197 Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT03152708 CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma Status UNKNOWN Phase N/A
NCT03152318 A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03151772 Bioavailability of Disulfiram and Metformin in Glioblastomas Status TERMINATED Phase EARLY_PHASE1
NCT03149575 VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM Status TERMINATED Phase PHASE3
NCT03149003 A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy Status COMPLETED Phase PHASE3
NCT03144167 Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy Status RECRUITING Phase NA
NCT03139916 Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE2
NCT03137888 Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma Status COMPLETED Phase PHASE2
NCT03119064 BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT03115138 Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas. Status TERMINATED Phase NA
NCT03107780 Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer Status TERMINATED Phase PHASE1
NCT03055208 Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma Status SUSPENDED Phase NA
NCT03050736 Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression Status COMPLETED Phase PHASE2
NCT03043391 Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children Status COMPLETED Phase PHASE1